Schmutzhard E, Pohl P, Stanek G
Department of Neurology, University Hospital, Innsbruck, Austria.
J Neurol Neurosurg Psychiatry. 1988 Sep;51(9):1215-8. doi: 10.1136/jnnp.51.9.1215.
Sera of 106 multiple sclerosis patients and 103 closely matched controls were examined for Borrelia burgdorferi antibodies. The prevalence rate in multiple sclerosis patients was 14.2%, in controls 25.2%. Overall prevalence was 20.1%. Mean IgG antibody level was insignificantly higher in controls than in multiple sclerosis patients. Patients with a chronic progressive course of multiple sclerosis had an insignificantly higher mean borrelia antibody level, when compared with those suffering from relapsing/remitting form of disease.
对106例多发性硬化症患者和103例紧密匹配的对照者的血清进行了伯氏疏螺旋体抗体检测。多发性硬化症患者的患病率为14.2%，对照者为25.2%。总体患病率为20.1%。对照组的平均IgG抗体水平略高于多发性硬化症患者，但差异不显著。与复发/缓解型疾病患者相比，慢性进展型多发性硬化症患者的平均伯氏疏螺旋体抗体水平略高，但差异不显著。
